Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Proteoglycans are a class of glycoproteins characterized by a core protein covalently attached to one or more glycosaminoglycan (GAG) chains. They are highly glycosylated, large molecules found predominantly in the extracellular matrix (ECM) of connective tissues, but also on cell surfaces and occasionally within cells. They provide structural support, bind water, regulate molecule movement, modulate protein activity, and serve as co-receptors. Alterations or defects in proteoglycans can contribute to diseases involving connective tissue integrity loss (e.g., osteoarthritis), abnormal wound healing/scarring/fibrosis processes, impaired neural regeneration after injury due to inhibitory effects on axon regrowth.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Proteoglycan (PG).